Strong Revenue Growth
Q4 revenue of $171M, up 46% year-over-year; full year 2025 revenue of $588M, up 51% year-over-year; LTM calculated billings of $671M, up 44% year-over-year.
Exceptional Profitability and Cash Generation
Q4 operating margin of 28% and full year 2025 operating margin of 20% (vs negative 7% in 2024); generated $62M free cash flow in Q4 and $180M for the full year 2025, representing a 36% and 31% free cash flow margin respectively.
Industry-Leading Efficiency (Rule of 40)
Rule of 40 metric of 82 in Q4 and 81 for full year 2025 — more than double the 40 standard, driven by high growth and strong free cash flow margins.
Rapid Commercial Expansion
Added ~4.8M net new contracted lives in 2025 to reach ~24.6M contracted lives across ~2,800 clients (25% YoY client growth); ended 2025 with ~783,000 active members, a 47% increase year-over-year.
Yield and Engagement Improvements
Yield (enrollment/engagement) improved over 50 basis points from 3.4% at end-2024 to 3.9% at end-2025; lifetime member activity surpassed 100M sessions with 41M sessions in 2025 (about 52 sessions per active member annualized).
Operational Leverage from AI
Served 47% more members in 2025 while keeping care team costs flat; average asynchronous care team time fell 28% from March 2025 in one quarter; AI care assistant 'Robin' has a 92% positive rating among early users.
High Retention and Clinical Validation
Annual client retention of 97% in 2025; net dollar retention well above 110%; published 21st peer‑reviewed outcomes study showing 60% fewer imaging visits for chronic back program participants at three months versus control.
Confident 2026 Guidance and Capital Position
Q1 2026 revenue guide $171–173M (approx. 39% YoY at midpoint); full year 2026 revenue guide $732–742M (approx. 25% YoY at midpoint), and projected non-GAAP operating margin ~21% for 2026. End-of-quarter cash and equivalents $479M and board authorized share repurchase program (up to $250M).